Recorded film highlights from the Annual General Meeting
The following slide presentations are a record of the Great Ormond Street Hospital Annual General Meeting (AGM) 2017.
- Welcome and introduction
Mary MacLeod and Nicola Grinstead
- Chief Executive Officer's Report
Dr Peter Steer
- Quality Report
Dr David Hicks
- Financial Report
- Annual Membership Update
Key highlights of the year
- 296,252 admissions and appointments
- 1,299 research studies with more than
- 4,000 patient and family members
- 4,384 members of staff
- Over 1,000 volunteers
Highlights of the year
- A new heart for Elliott – After more than 400 days on Bear Ward, heart transplant patient Elliott finally returned home
- A ‘super’ new facility – In October 2016, nine-year-old Ben became the first patient to be treated with Gamma Knife surgery at GOSH - an effective, non-invasive, alternative to neurosurgery
- Double lung transplant – Imogen was only five months old when she had a double lung transplant at GOSH making her the smallest child to ever have the operation in the UK
- Vitamin B6 lifesaver discovery – Children with severe epilepsy who do not respond to traditional drugs could be treated with vitamin B6, after the discovery of a new gene by UCL Great Ormond Street Institute of Child Health and its clinical partner Great Ormond Street Hospital
Our major development phases are in full flow – replacing old and inadequate buildings.
Upgrading our estate allows us to offer world-class treatment to more children. It also means we can care for them and their families in safer, more comfortable environments.
- We’re approaching completion of Phase 2b of redevelopment plan – the first service moves start in November 2017 and the whole building will be open by Spring 2018.
- The Zayed Centre for Research into Rare Disease (Phase 3) will contain outpatients clinics, research laboratories and a Good Manufacturing Practice (GMP) facility to create specialist products for clinical trials and new treatments. Frame construction is up to Level 4 and the building will ‘top out’ (reach its highest point) by the end of the year. The redevelopment project is due to complete at the end of 2018.
- A decision on the planning application for the Italian Hospital is due imminently. If approved, a decant plan will be developed and construction is anticipated to run from May 2018 until Summer 2019.
- Public engagement on three early design concepts for phase 4, the proposed replacement of the Frontage and Paul O’Gorman buildings, included public exhibitions attended by 500 stakeholders and an evaluation by the Members’ Council and YPF
International private patients (IPP)
- IPP is essential in providing revenue to support our highly specialised NHS services.
- We have implemented our plan to develop our International and Private Patients (IPP) services and achieved significant growth in this area over the past two years. This year we met this rising demand by opening Hedgehog Ward, bringing our number of dedicated beds to 53. Our development of IPP-generated income growth of 14.1% this year, to be invested in NHS services for the benefit of all our patients.
- Important in bringing in large numbers of patients with rare diseases to assist in our research to discover new treatments and cures for children worldwide.
- The majority of private patient service demand is from the Middle East, which carries a degree of geopolitical risk. The Trust continues to implement its strategic objectives to mitigate exposure to this risk through market and product development opportunities.
- We have improved the monitoring and escalation of the deteriorating child by implementing the GOSH Sepsis 6 protocol and implemented safety huddles
- We have reduced the number of patients with incomplete pathways at 18 week
- We have implemented mental health screening in children and young people with long-term physical health conditions
- We have improved young people’s experience of transition to adult services
- We have utilised Friends and Family Test data for improvement